4
Changes in Ownership
Opus Genetics, Inc. Filed Acc 0001140361-14-034948
Options or other derivatives
- Chief Executive Officer acquired 1,000,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Suzdak Peter David · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2014-09-04 | Grant or award : show line 1 in the form Stock Option (right to purchase) | +1,000,000 | $0.83 | 2024-09-04 | 1,000,000 | 1,000,000 | D |
Loading xslF345X03/doc1.xml…